Market Tracker

04/26 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

33.66
Delayed Data
As of 3:59pm ET
 -1.05 / -3.03%
Today’s Change
20.68
Today|||52-Week Range
42.49
+16.71%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close34.71
Today’s open35.00
Day’s range33.61 - 35.22
Volume1,394,637
Average volume (3 months)2,134,385
Market cap$4.2B
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-18.25%
Earnings growth (next 5 years)+36.20%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book8.13

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+2.32+0.27%
AKRXAkorn Inc+0.09+0.27%
OPKOPKO Health Inc0.000.00%
ALNYAlnylam Pharmaceutic...+2.67+5.20%
Data as of 4:02pm ET, 04/26/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts